Adaptive Biotechnologies Corp — Director's Dealing 2022

Nov 17, 2022

SEC Form 4/A — Form 4/A

Issuer: Adaptive Biotechnologies Corp (ADPT)
CIK: 0001478320
Period of Report: 2022-11-16

Reporting Person: PISKEL KYLE (Principal Accounting Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-11-16	Common Stock	S	307	$8.87	Disposed	47358	Direct

Footnotes

F1: This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding olbigaitons to e funded by a sell to cover transaction and does not represent a discretionary trade.